CoChat

DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer

Open access
Carmona, F. Javier, Azuara, Daniel, Berenguer-Llergo, Antonio, Fernández, Agustin F., Biondo, Sebastiano, de Oca, Javier, Rodriguez-Moranta, Francisco, Salazar, Ramón, Villanueva, Alberto, Fraga, Mario F., Guardiola, Jordi, Capellá, Gabriel, Esteller, Manel, Moreno, Victor · 2013 · Cancer Prevention Research
Cited by 124

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer (CRC) and precursor lesions have been extensively studied. Different panels have been reported attempting to improve current protocols in clinical practice, although no definite biomarkers have been established. In the present study, we have examined patient biopsies starting from a comprehensive analysis of DNA methylation differences between paired normal and tumor samples in known cancer-related genes aiming to select the best performing candidates informative for CRC diagnosis in stool samples. Five selected markers were considered for subsequent analyses in independent biologic cohorts and in silico data sets. Among the five selected genes, three of them (AGTR1, WNT2 and SLIT2) were validated in stool DNA of affected patients with a detection sensitivity of 78% [95% confidence interval (CI), 56%–89%]. As a reference, DNA methylation of VIM and SEPT9 was evaluated in a subset of stool samples yielding sensitivities of 55% and 20%, respectively. Moreover, our panel may complement histologic and endoscopic diagnosis of inflammatory bowel disease (IBD)-associated neoplasia, as it was also efficient detecting aberrant DNA methylation in non-neoplastic tissue samples from affected patients. This novel panel of specific methylation markers can be useful for early diagnosis of CRC using stool DNA and may help in the follow-up of high-risk patients with IBD. Cancer Prev Res; 6(7); 656–65. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1940-6207.capr-12-0501

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 124

Metadata

Authors
Carmona, F. J., Azuara, D., Berenguer-Llergo, A., Fernández, A. F., Biondo, S., de Oca, J., Rodriguez-Moranta, F., Salazar, R., Villanueva, A., Fraga, M. F., Guardiola, J., Capellá, G., Esteller, M., & Moreno, V.
Venue
Cancer Prevention Research
Published
2013-07-01
Volume
6
Issue
7
Pages
656-665
ISSN
  • 1940-6207 (ISSN-L)
  • 1940-6215
OpenAlex
W2140149776
Cited by
124
References
3
FWCI
6.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1940-6207.capr-12-0501
The paper
Carmona, F. J., Azuara, D., Berenguer-Llergo, A., Fernández, A. F., Biondo, S., de Oca, J., Rodriguez-Moranta, F., Salazar, R., Villanueva, A., Fraga, M. F., Guardiola, J., Capellá, G., Esteller, M., & Moreno, V. (2013). DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-12-0501

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.